摘要
目的 观察尿激酶治疗急性脑梗死的效果与安全性。方法 32例急性脑梗死患者随机分为两组。治疗组给予尿激酶、灯盏花素注射液治疗 ,并检测入院即刻、6h、1d、3d、5d周围静脉血中D 二聚体水平、纤维蛋白原含量 (FIB)、纤维蛋白降解产物 (FDP)、凝血时间 (TT)、凝血酶原时间 (PT)、活化的部分凝血活酶时间 (APTT) ,进行动态观察。对照组给予灯盏花素治疗。结果 治疗组疗效与血液流变学的改善 ,明显优于对照组 (P <0 .0 1)。结论 采用尿激酶和灯盏花素注射液治疗脑梗死安全性大 ,未发现出血、过敏等副作用 ,发病超过 6h进行溶栓 。
Objective To evaluate the effects and security of urokinase on cerebral infarction.Methods thirty-two cases of acute cerebral infarction were randomly divided into two groups in order to understand effect and security of urokinase treatment on the disease,and urokinase was given separately as injection breviscapini and breviscapini.Results The effects in treat group were superior to that in control group and there was an extremely remarkable difference in clinic effect and improvement of bloodstream change (P<0.01).Conclusion To dissolve embolus still had certain effect for the patients of more than 6 h disease time.It had high security and no side effect,such as hemorrhage,allergy.
出处
《江西医学院学报》
2004年第2期54-56,共3页
Acta Academiae Medicinae Jiangxi
关键词
脑梗死
急性
尿激酶
灯盏花素注射液
acute cerebral infarcti
urokinase
injectio breviscapini
